Versant Ventures

Versant Ventures is a prominent healthcare investment firm dedicated to supporting exceptional entrepreneurs in developing innovative healthcare solutions. With over $5.5 billion under management, the firm invests across the healthcare sector, emphasizing the discovery and development of novel therapeutics. Versant Ventures operates from multiple offices in the United States, Canada, and Europe, including San Francisco, New York, San Diego, Toronto, Vancouver, and Basel.

The firm's investment strategy encompasses various stages of company development, from seed to pre-IPO, focusing on biotechnology, medical devices, healthcare services, and health IT sectors. Versant Ventures has a strong track record, with more than 100 portfolio companies achieving successful acquisitions or IPOs since its founding in 1999. This success is attributed to its deep investment, operational, and scientific expertise, enabling a hands-on approach to company building.

In addition to its investment activities, Versant Ventures has established several discovery engines, such as Inception in San Diego and Ridgeline in Basel, to foster the creation of new biotechnology companies. These initiatives reflect the firm's commitment to advancing healthcare innovation and supporting the growth of transformative healthcare companies worldwide.